DNABW (Ginkgo Bioworks Holdings) Growth Rank: 6 (As of Aug. 12, 2026) — 100% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DNABW Ginkgo Bioworks Holdings Inc DNABW
65 GF Score
Price $0.00
! 5 Warning Signs
View Full Analysis

What is Ginkgo Bioworks Holdings Growth Rank?

Ginkgo Bioworks Holdings DNABW 65 Growth Rank is 6 as of Aug. 12, 2026, which is 100% above its 10-year median of 3.00. GuruFocus rates DNABW with a GF Score™ of 65/100. The stock has 5 warning signs investors should review.

Ginkgo Bioworks Holdings has the Growth Rank of 6.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.


Ginkgo Bioworks Holdings Growth Rank Related Terms


DNABW vs RZLT, EIKN, ARTV: Growth Rank Comparison

For the Biotechnology subindustry, Ginkgo Bioworks Holdings's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ginkgo Bioworks Holdings Growth Rank vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ginkgo Bioworks Holdings's Growth Rank distribution charts can be found below:

* The bar in red indicates where Ginkgo Bioworks Holdings's Growth Rank falls into.


DNABW
65GF Score
Ginkgo Bioworks Holdings Inc DNABW
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 6 mean?
Ginkgo Bioworks Holdings (DNABW) has a Growth Rank of 6 as of Aug. 12, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Ginkgo Bioworks Holdings and its competitors. This is 100% above median its historical median of 3.00. Over the past decade, Ginkgo Bioworks Holdings' Growth Rank has ranged from 3.00 to 9.00.
Is Ginkgo Bioworks Holdings' Growth Rank too high?
Ginkgo Bioworks Holdings' current Growth Rank of 6 is 100% above median its 10-year median of 3.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 9.00. Overall, Ginkgo Bioworks Holdings has a GF Score™ of 65/100, reflecting its overall financial health beyond just this single metric.
How does Ginkgo Bioworks Holdings' Growth Rank compare to RZLT and EIKN?
Ginkgo Bioworks Holdings' Growth Rank of 6 can be compared against companies in the Biotechnology industry. Historically, Ginkgo Bioworks Holdings' own Growth Rank has ranged from 3.00 to 9.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Biotechnology company?
A good Growth Rank depends on the Biotechnology industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Ginkgo Bioworks Holdings and its competitors. Ginkgo Bioworks Holdings's current Growth Rank is 6, which is 100% above median its own 10-year median of 3.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ginkgo Bioworks Holdings stock overvalued right now?
Ginkgo Bioworks Holdings (DNABW) has a current Growth Rank of 6. The current Growth Rank is 6, which is 100% above median its 10-year median of 3.00. Ginkgo Bioworks Holdings' overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Ginkgo Bioworks Holdings (DNABW), the current Growth Rank is 6 as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ginkgo Bioworks Holdings Business Description

Other Exchanges DNA:USADNA:Mexico
Address 27 Drydock Avenue, 8th Floor, Boston, MA, USA, 02210
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
65GF Score

Get the complete analysis for DNABW

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price